Literature DB >> 11872187

Should butalbital-containing analgesics be banned? Yes.

William B Young1, Hua Chiang Siow.   

Abstract

In the United States analgesic-overuse headache is often caused by butalbital-containing analgesics. These agents can cause physical and psychological dependency, and dangerous withdrawal syndromes. Butalbital-containing analgesics have already been banned in several European countries. They are proven effective in tension-type headache, but not in migraine; there are many alternative treatments for migraine and tension-type headache. In the 20 years since analgesic overuse headache was widely recognized, butalbital overuse has remained distressingly common. It is time to ban these agents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872187     DOI: 10.1007/s11916-002-0012-y

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  39 in total

1.  Kaplan Award 1998. Epidemiology of chronic daily headache in the general population.

Authors:  J Castillo; P Muñoz; V Guitera; J Pascual
Journal:  Headache       Date:  1999-03       Impact factor: 5.887

2.  Does analgesic abuse cause headaches de novo?

Authors:  F Lance; C Parkes; M Wilkinson
Journal:  Headache       Date:  1988-02       Impact factor: 5.887

Review 3.  Analgesic rebound headache.

Authors:  A M Rapoport
Journal:  Headache       Date:  1988-11       Impact factor: 5.887

4.  Ergotamine tartrate dependency: features and possible mechanisms.

Authors:  J R Saper; J M Jones
Journal:  Clin Neuropharmacol       Date:  1986       Impact factor: 1.592

5.  Symptomatic treatment of chronically recurring tension headache: a placebo-controlled, multicenter investigation of Fioricet and acetaminophen with codeine.

Authors:  A P Friedman; F J DiSerio
Journal:  Clin Ther       Date:  1987       Impact factor: 3.393

6.  Fiorinal with Codeine in the management of tension headache: impact of placebo response.

Authors:  D S Hwang; M J Mietlowski; A P Friedman
Journal:  Clin Ther       Date:  1987       Impact factor: 3.393

7.  Impact of headache on sickness absence and utilisation of medical services: a Danish population study.

Authors:  B K Rasmussen; R Jensen; J Olesen
Journal:  J Epidemiol Community Health       Date:  1992-08       Impact factor: 3.710

8.  Migraine and reduced work performance: a population-based diary study.

Authors:  M Von Korff; W F Stewart; D J Simon; R B Lipton
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

9.  Headache as a model for assessing mild analgesic drugs.

Authors:  B von Graffenried; R C Hill; E Nüesch
Journal:  J Clin Pharmacol       Date:  1980 Feb-Mar       Impact factor: 3.126

10.  Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches.

Authors:  C Baumgartner; P Wessely; C Bingöl; J Maly; F Holzner
Journal:  Headache       Date:  1989-09       Impact factor: 5.887

View more
  2 in total

Review 1.  Tension-type headache with medication overuse: pathophysiology and clinical implications.

Authors:  Teshamae S Monteith; Michael L Oshinsky
Journal:  Curr Pain Headache Rep       Date:  2009-12

2.  Didactic migraine education in US doctor of pharmacy programs.

Authors:  Richard G Wenzel; Rosalyn S Padiyara; Jon C Schommer
Journal:  Am J Pharm Educ       Date:  2010-02-10       Impact factor: 2.047

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.